Sickle Cell Disease Treatment Market: Hoffmann-La Roche, Mylan, and...

adicionou um novo artigo Outro

2025-01-20 07:32:04 -

Sickle Cell Disease Treatment Market: Hoffmann-La Roche, Mylan, and Teva’s Pioneering Therapies

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, Growing at a CAGR of 20.00% From 2024-2032. The Sickle Cell Disease (SCD) Market is rapidly evolving, pushed through the growing popularity of the need for powerful treatments for this inherited blood sickness. Sickle mobile sickness, which in the main affects people of...

0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior